Physicians’ Education Resource® Announces Six Satellite Symposia at 37th Annual Miami Breast Cancer Conference®

Activities will cover emerging strategies and pressing challenges faced by the breast cancer community

CRANBURY, N.J.--(BUSINESS WIRE)-- Physicians’ Education Resource® (PER®), a leading resource for continuing medical education (CME), will conduct six CME-accredited satellite symposia during the 37^th Annual Miami Breast Cancer Conference® at the Fontainebleau in Miami Beach, Florida, March 5-8.

“Our all-inclusive breast cancer conference is one of our biggest and most influential programs of the year,” said Phil Talamo, president of PER®. “This year we excited more than ever offering additional CME educational opportunities such as invaluable expert insights from world-renowned thought leaders, engaging symposia sessions and legendary medical crossfires. Join us in March, you won’t want to miss the 37th Annual Miami Breast Cancer Conference^®.”

The PER® satellite symposia are as follows:

• Coffee Talk: Initiating Early Recognition and Intervention in a Rare Lymphoma Associated With Breast Implants, which will be held Thursday, March 5, from 9:15 to 10:45 a.m., in the meeting room Fontaine. The program will be chaired by Lloyd B. Gayle, M.D., FACS, chief of plastic surgery and vice chair of surgery, Maimonides Medical Center in Brooklyn, New York; and clinical associate professor of surgery, Weill Medical College of Cornell University in New York. To register, click here.
• Managing Postoperative Pain: The Clinical Impact of Opioid-Sparing Strategies on Patients with Breast Cancer, which will be held Thursday, March 5, from 7 to 8:30 p.m., in the meeting room Fontaine. The program will be chaired by Patrick I. Borgen, M.D., chair of the department of surgery and director, breast cancer program, Maimonides Medical Center in Brooklyn, New York. To register, click here.
• Coffee Talk: Perspectives on PARP, HER2/3, PI3K, and Emerging Oncogenic Targets in Breast Cancer Care, which will be held Friday, March 6, from 7 to 8:30 a.m., in the meeting room Fontaine. The program will be chaired by Mark E. Robson, M.D., chief, breast medicine service, and attending physician, breast medicine and clinical genetics services, Memorial Sloan Kettering Cancer Center; and professor of medicine, Weill Cornell Medical College in New York. To register, click here.
• Leveraging Immunogenicity to Optimize Patient Outcomes in Triple Negative Breast Cancer: Current and Emerging Evidence, which will be held Friday, March 6, from 6:30 to 8:00 p.m., in the meeting room Fontaine. The program will be chaired by Joyce O’Shaughnessy, M.D., the Celebrating Women Chair in Breast Cancer Research, Texas Oncology-Baylor Charles A. Sammons Cancer Center; and chair, breast cancer research program, The US Oncology Network in Dallas, Texas. To register, click here.
• Medical Crossfire®: Real World Scenarios and Applications for Biosimilars in HER2-Positive Breast Cancer: Key Concepts for Clinical Decision-Making, which will be held Saturday, March 7, from 7 to 8:30 a.m., in the meeting room Fontaine. The program will be chaired by Hope S. Rugo, M.D., FASCO, professor of medicine, department of medicine (hematology/oncology), and director, breast oncology clinical trials program, University of California San Francisco Helen Diller Family Comprehensive Cancer Center in California. To register, click here.
• How We Do it: Personalizing Treatment for Patients With HER2-Positive Breast Cancer, which will be held Sunday, March 8, from 7 to 8:30 a.m., in the meeting room Fontaine. The program will be chaired by Debu Tripathy, M.D., professor and chair, department of breast medical oncology, The University of Texas MD Anderson Cancer Center in Houston. To register, click here.

Each satellite is accredited by the Accreditation Council for Continuing Medical Education for 1.5 AMA PRA Category 1 Credits™ for physicians.

For more information and to view the full agenda, click here.

About Physicians’ Education Resource® (PER®)

Since 1995, PER® has been dedicated to advancing cancer care through professional education and now advances patient care and treatment strategies on a wide variety of chronic illnesses and diseases. In 2016, PER® initiated continuing medical education (CME) programming in the cardiovascular and endocrinology areas. As well as expanding into topics outside of oncology, PER® stands as the leading provider of live, online and print CME activities related to oncology and hematology. The high-quality, evidence-based activities feature leading distinguished experts who focus on the application of practice-changing advances. PER® is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER® is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200220005811/en/